RIPK1-IN-25
RIPK1-IN-25 (WL8) is a blood-brain permeable RIPK1 inhibitor with EC50 and Kd values are 19.9 and 25 nM, respectively. RIPK1-IN-25 can be used in the study of neurometabolic diseases[1].
Product Specifications
UNSPSC
12352005
Target
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ripk1-in-25.html
Smiles
CC1=C(F)C=C(C2CC=NN2C(C3CCN(C(C4=CC=CC(F)=N4)=O)CC3)=O)C=C1
Molecular Formula
C22H22F2N4O2
Molecular Weight
412.43
References & Citations
[1]Li W, et al. Structure-based discovery of a 4,5-Dihydropyrazole-cored PET ligand for imaging of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) in the brain. Eur J Med Chem. 2024 Sep 2;279:116803.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![GTF2IRD1 Mouse Monoclonal Antibody [Clone ID: OTI9A3]](https://cdn.genprice.uk/products/937/68dd18ba061270361e90878e/imageurl/cf809948.webp)
S5380-15 100 µL
Spectrin, beta 2 (Spectrin beta Chain Brain 2, Spectrin beta Non-erythrocytic 2, SPTBN2, Spectrin Non-erythroid beta Chain 2, Spinocerebellar Ataxia 5, SCA5)
Ask
View Details MBS1095649-01 0.02 mg (E-Coli)
Recombinant Haemophilus influenzae Uncharacterized protein HI_1340 (HI_1340)
Ask
View Details